Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block
Overview
Affiliations
Given that diseases associated with anti-SSA/Ro autoantibodies, such as systemic lupus erythematosus and Sjögren syndrome, are linked with an upregulation of IFN and type I IFN-stimulated genes, including sialic acid-binding Ig-like lectin 1 (Siglec-1), a receptor on monocytes/macrophages, recent attention has focused on a potential role for IFN and IFN-stimulated genes in the pathogenesis of congenital heart block (CHB). Accordingly, three approaches were leveraged to address the association of IFN, IFN-stimulated genes, and the phenotype of macrophages in affected fetal cardiac tissue: 1) cultured healthy human macrophages transfected with hY3, an anti-SSA/Ro-associated ssRNA, 2) RNA isolated from freshly sorted human leukocytes/macrophages after Langendorff perfusion of three fetal hearts dying with CHB and three healthy gestational age-matched hearts, and 3) autopsy tissue from three additional human CHB hearts and one healthy heart. TLR ligation of macrophages with hY3 led to the upregulation of a panel of IFN transcripts, including SIGLEC1, a result corroborated using quantitative PCR. Using independent and agnostic bioinformatics approaches, CD45CD11c and CD45CD11c human leukocytes flow sorted from the CHB hearts highly expressed type I IFN response genes inclusive of SIGLEC1. Furthermore, Siglec-1 expression was identified in the septal region of several affected fetal hearts. These data now provide a link between IFN, IFN-stimulated genes, and the inflammatory and possibly fibrosing components of CHB, positioning Siglec-1-positive macrophages as integral to the process.
Gamba A, Zen M, Depascale R, Calligaro A, Gatto M, Iaccarino L J Clin Med. 2024; 13(12).
PMID: 38929983 PMC: 11204490. DOI: 10.3390/jcm13123454.
Di Ludovico A, Rinaldi M, Mainieri F, Di Michele S, Girlando V, Ciarelli F Int J Mol Sci. 2024; 25(10).
PMID: 38791261 PMC: 11120786. DOI: 10.3390/ijms25105224.
Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer.
Elfstrum A, Bapat A, Schwertfeger K Cancer Med. 2024; 13(3):e7053.
PMID: 38426622 PMC: 10905685. DOI: 10.1002/cam4.7053.
Bedei I, Kniess D, Keil C, Wolter A, Schenk J, Sachs U J Clin Med. 2024; 13(4).
PMID: 38398455 PMC: 10889801. DOI: 10.3390/jcm13041142.
Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study.
Mehta P, Chattopadhyay P, Mohite R, DRozario R, Bandopadhyay P, Sarif J Life Sci Alliance. 2023; 7(1).
PMID: 37918965 PMC: 10622646. DOI: 10.26508/lsa.202302305.